相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis
Radha Mukherjee et al.
MOLECULAR CELL (2021)
Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition
Meagan B. Ryan et al.
CLINICAL CANCER RESEARCH (2020)
Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Shannon Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumors
Xi Yuan et al.
MOLECULAR ONCOLOGY (2020)
Periodic propagating waves coordinate RhoGTPase network dynamics at the leading and trailing edges during cell migration
Alfonso Bolado-Carrancio et al.
ELIFE (2020)
Structural basis for the action of the drug trametinib at KSR-bound MEK
Zaigham M. Khan et al.
NATURE (2020)
Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma Cells
Luca Gerosa et al.
CELL SYSTEMS (2020)
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Targeting Alterations in the RAF-MEK Pathway
Rona Yaeger et al.
CANCER DISCOVERY (2019)
A universal biomolecular integral feedback controller for robust perfect adaptation
Stephanie K. Aoki et al.
NATURE (2019)
SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics
Isabel Boned del Rio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
S. Kopetz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Mechanisms of acquired tumor drug resistance
Svetlana N. Aleksakhina et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Mapping connections in signaling networks with ambiguous modularity
Daniel Lill et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2019)
The challenge of drug resistance in cancer treatment: a current overview
Michail Nikolaou et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
Inflammatory but not mitogenic contexts prime synovial fibroblasts for compensatory signaling responses to p38 inhibition
Douglas S. Jones et al.
SCIENCE SIGNALING (2018)
Inflammatory but not mitogenic contexts prime synovial fibroblasts for compensatory signaling responses to p38 inhibition
Douglas S. Jones et al.
SCIENCE SIGNALING (2018)
Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS Signaling
Oleksii S. Rukhlenko et al.
CELL SYSTEMS (2018)
Impact of measurement noise, experimental design, and estimation methods on Modular Response Analysis based network reconstruction
Caterina Thomaseth et al.
SCIENTIFIC REPORTS (2018)
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors
Ivana Yen et al.
CANCER CELL (2018)
Divergent effects of intrinsically active MEK variants on developmental Ras signaling
Yogesh Goyal et al.
NATURE GENETICS (2017)
RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKα
Andrea Varga et al.
SCIENCE SIGNALING (2017)
RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKα
Andrea Varga et al.
SCIENCE SIGNALING (2017)
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling (vol 30, pg 485, 2016)
Zoi Karoulia et al.
CANCER CELL (2016)
Negative feedback regulation of the ERK1/2 MAPK pathway
David Lake et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
MAPK kinase signalling dynamics regulate cell fate decisions and drug resistance
Nora Rauch et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2016)
Integrating network reconstruction with mechanistic modeling to predict cancer therapies
Melinda Halasz et al.
Science Signaling (2016)
Feedback regulation in cell signalling: Lessons for cancer therapeutics
Lan K. Nguyen et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering
Olga Blazevits et al.
SCIENTIFIC REPORTS (2016)
Integrating network reconstruction with mechanistic modeling to predict cancer therapies
Melinda Halasz et al.
Science Signaling (2016)
Antithetic Integral Feedback Ensures Robust Perfect Adaptation in Noisy Biomolecular Networks
Corentin Briat et al.
CELL SYSTEMS (2016)
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
Douglas B. Johnson et al.
EUROPEAN JOURNAL OF CANCER (2015)
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer
Ryan B. Corcoran et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial
Jean Jacques Grob et al.
LANCET ONCOLOGY (2015)
Silence on the relevant literature and errors in implementation
Philippe Bastiaens et al.
NATURE BIOTECHNOLOGY (2015)
Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant Transformation
Malgorzata Milewska et al.
PLOS ONE (2015)
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
Dirk Fey et al.
SCIENCE SIGNALING (2015)
Promoter-level expression clustering identifies time development of transcriptional regulatory cascades initiated by ErbB receptors in breast cancer cells
Marco Mina et al.
SCIENTIFIC REPORTS (2015)
Drug Resistance Resulting from Kinase Dimerization Is Rationalized by Thermodynamic Factors Describing Allosteric Inhibitor Effects
Boris N. Kholodenko
CELL REPORTS (2015)
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
Dirk Fey et al.
SCIENCE SIGNALING (2015)
Resistance to receptor tyrosine kinase inhibition in cancer: molecular mechanisms and therapeutic strategies
Peter B. Alexander et al.
FRONTIERS OF MEDICINE (2015)
Coupling between the Circadian Clock and Cell Cycle Oscillators: Implication for Healthy Cells and Malignant Growth
Celine Feillet et al.
Frontiers in Neurology (2015)
The dynamic control of signal transduction networks in cancer cells
Walter Kolch et al.
NATURE REVIEWS CANCER (2015)
Consequences of feedback in signal transduction for targeted therapies
Bertram Klinger et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling
Jacob R. Haling et al.
CANCER CELL (2014)
Dimeric Structure of Pseudokinase RNase L Bound to 2-5A Reveals a Basis for Interferon-Induced Antiviral Activity
Hao Huang et al.
MOLECULAR CELL (2014)
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Chong Sun et al.
NATURE (2014)
Protein interaction switches coordinate Raf-1 and MST2/Hippo signalling
David Romano et al.
NATURE CELL BIOLOGY (2014)
Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
James Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies
Chong Sun et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Rule-based modeling: a computational approach for studying biomolecular site dynamics in cell signaling systems
Lily A. Chylek et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2014)
Complex Relationship between Ligand Binding and Dimerization in the Epidermal Growth Factor Receptor
Nicholas J. Bessman et al.
CELL REPORTS (2014)
Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity
Nobuya Ishii et al.
CANCER RESEARCH (2013)
Allosteric Activation of Functionally Asymmetric RAF Kinase Dimers
Jiancheng Hu et al.
CELL (2013)
Dual-specificity MAP kinase phosphatases (MKPs): Shaping the outcome of MAP kinase signalling
Christopher J. Caunt et al.
FEBS JOURNAL (2013)
Network quantification of EGFR signaling unveils potential for targeted combination therapy
Bertram Klinger et al.
MOLECULAR SYSTEMS BIOLOGY (2013)
Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer
Matthew J. Niederst et al.
SCIENCE SIGNALING (2013)
Complexity of Receptor Tyrosine Kinase Signal Processing
Natalia Volinsky et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Relief of Feedback Inhibition of HER3 Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in BRAF-Mutant Thyroid Carcinomas
Cristina Montero-Conde et al.
CANCER DISCOVERY (2013)
Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas
Piro Lito et al.
CANCER CELL (2012)
The topology design principles that determine the spatiotemporal dynamics of G-protein cascades
Mikhail A. Tsyganov et al.
MOLECULAR BIOSYSTEMS (2012)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
Priya Koppikar et al.
NATURE (2012)
Divergent allosteric control of the IRE1α endoribonuclease using kinase inhibitors
Likun Wang et al.
NATURE CHEMICAL BIOLOGY (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors
Dalia Ercan et al.
CANCER DISCOVERY (2012)
Crosstalk and signaling switches in mitogen-activated protein kinase cascades
Dirk Fey et al.
FRONTIERS IN PHYSIOLOGY (2012)
AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
Sarat Chandarlapaty et al.
CANCER CELL (2011)
Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors
Oreste Segatto et al.
JOURNAL OF CELL SCIENCE (2011)
Ligand-Specific c-Fos Expression Emerges from the Spatiotemporal Control of ErbB Network Dynamics
Takashi Nakakuki et al.
CELL (2010)
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Sonja J. Heidorn et al.
CELL (2010)
Impact of Feedback Phosphorylation and Raf Heterodimerization on Normal and Mutant B-Raf Signaling
Daniel A. Ritt et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikos I. Poulikakos et al.
NATURE (2010)
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Georgia Hatzivassiliou et al.
NATURE (2010)
The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier
Oliver E. Sturm et al.
SCIENCE SIGNALING (2010)
Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas
Matthew J. Frank et al.
BLOOD (2009)
Toggle switches, pulses and oscillations are intrinsic properties of the Src activation/deactivation cycle
Nikolai P. Kaimachnikov et al.
FEBS JOURNAL (2009)
SYSTEMS MICROBIOLOGY - OPINION Drug interactions and the evolution of antibiotic resistance
Pamela J. Yeh et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Phosphatase-mediated crosstalk between MAPK signalling pathways in the regulation of cell survival
Melissa R. Junttila et al.
FASEB JOURNAL (2008)
Domain-oriented reduction of rule-based network models
N. M. Borisov et al.
IET SYSTEMS BIOLOGY (2008)
Mitogen-activated protein (MAP) Kinase/MAP kinase phosphatase regulation: Roles in cell growth, death, and cancer
Tarek Boutros et al.
PHARMACOLOGICAL REVIEWS (2008)
Bistability and oscillations in the Huang-Ferrell model of MAPK signaling
Liang Qiao et al.
PLOS COMPUTATIONAL BIOLOGY (2007)
A module of negative feedback regulators defines growth factor signaling
Ido Amit et al.
NATURE GENETICS (2007)
Quantifying gene network connectivity in silico: scalability and accuracy of a modular approach
N. Yalamanchili et al.
IEE PROCEEDINGS SYSTEMS BIOLOGY (2006)
Chemical genetic analysis of the time course of signal transduction by JNK
JJ Ventura et al.
MOLECULAR CELL (2006)
Regulation and role of Raf-1/B-Raf heterodimerization
LK Rushworth et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Cell-signalling dynamics in time and space
BN Kholodenko
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Mechanistic link between PKR dimerization, autophosphorylation, and elF2α substrate recognition
M Dey et al.
CELL (2005)
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
W Pao et al.
PLOS MEDICINE (2005)
Multicomponent therapeutics for networked systems
CT Keith et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Structure and function of the feed-forward loop network motif
S Mangan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Untangling the wires: A strategy to trace functional interactions in signaling and gene networks
BN Kholodenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling
ESM Wong et al.
EMBO JOURNAL (2002)
Robust perfect adaptation in bacterial chemotaxis through integral feedback control
TM Yi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades
BN Kholodenko
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
分享论文
